DNA Repair Genes ERCC1 and BRCA1 Expression in Non-Small Cell Lung Cancer Chemotherapy Drug Resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DNA Repair Genes ERCC1 and BRCA1 Expression in Non-Small Cell Lung Cancer Chemotherapy Drug Resistance

Published:2016-06-12 Issue: Volume:22 Page:1999-2005
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Wang Shuai¹,Liu Feng²,Zhu Jingyan³,Chen Peng³,Liu Hongxing³,Liu Qi⁴,Han Junqing⁵

Affiliation:

1. Shandong University, Jinan, Shandong, China (mainland)

2. WeiFang Medical University, Weifang, Shandong, China (mainland)

3. Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, Shandong, China (mainland)

4. Institute of Oncology, Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong, China (mainland)

5. Department of Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer;Cells;2023-05-25

2. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin;World Journal of Gastrointestinal Oncology;2023-02-15

3. XPF-ERCC1 blocker improves the therapeutic efficacy of 5-FU- and oxaliplatin-based chemoradiotherapy in rectal cancer;2022-12-05

4. Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer;Journal of Personalized Medicine;2022-10-04

5. The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions;Experimental and Molecular Pathology;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3